Spleen Tyrosine Kinase (Syk) Regulates Systemic Lupus Erythematosus T Cell Signaling

被引：0
|
作者：
Grammatikos, Alexandros P. [1 ]
Ghosh, Debjani [2 ]
Kyttaris, Vasileios C. [3 ]
机构：
[1] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA
[2] E Carolina Univ, Brody Sch Med, Greenville, NC USA
[3] Harvard Univ, Sch Med, BIDMC, Boston, MA USA
来源：
ARTHRITIS AND RHEUMATISM | 2013年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2701
引用
收藏
页码：S1154 / S1154
页数：1
相关论文
共 50 条
  • [41] High prevalence of T cell type I protein kinase a deficiency in systemic lupus erythematosus
    Kammer, GM
    ARTHRITIS AND RHEUMATISM, 1999, 42 (07): : 1458 - 1465
  • [42] Spleen tyrosine kinase mediates the γδTCR signaling required for γδT cell commitment and γδT17 differentiation
    Muro, Ryunosuke
    Narita, Tomoya
    Nitta, Takeshi
    Takayanagi, Hiroshi
    FRONTIERS IN IMMUNOLOGY, 2023, 13
  • [43] Peripheral B cell abnormalities in patients with SLE are linked to disturbances of the spleen tyrosine kinase (Syk)
    Fleischer, S.
    Daridon, C.
    Doerner, T.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 : 45 - 46
  • [44] The spleen tyrosine kinase (Syk) in human disease, implications for design of tyrosine kinase inhibitor based therapy
    Navara, CS
    CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (15) : 1739 - 1744
  • [45] Estradiol Differentially Regulates Calreticulin: A Potential Link with Abnormal Calcium Signaling in Systemic Lupus Erythematosus T Cells?
    Ward, J.
    Rider, V.
    Abdou, N.
    Kimler, B.
    MOLECULAR BIOLOGY OF THE CELL, 2011, 22
  • [46] Novel therapeutic strategies targeting abnormal T-cell signaling in systemic lupus erythematosus
    Mizui, Masayuki
    Kono, Michihito
    CLINICAL IMMUNOLOGY, 2024, 262
  • [47] SPLEEN TYROSINE KINASE (SYK) IS A NOVEL THERAPEUTIC TARGET FOR INTRAHEPATIC CHOLANGIOCARCINOMA
    Yuan, Hui
    Lin, Zelong
    Liu, Yingjun
    Weng, Xie
    Zhou, Yuchen
    Tu, Mengxian
    Zheng, Dandan
    Li, Jinying
    He, Lu
    Qu, Chen
    Wu, Ziqing
    Hong, Jian
    HEPATOLOGY, 2019, 70 : 559A - 560A
  • [48] Activity of spleen tyrosine kinase (Syk) is required for development of colitis in mice
    Kraneveld, Aletta
    Rijnierse, Anneke
    Herlaar, Ellen
    Singh, Rajinder
    Payan, Donald
    Schmitz, Jochen
    Bunnett, Nigel W.
    GASTROENTEROLOGY, 2007, 132 (04) : A230 - A230
  • [49] Targeting spleen tyrosine kinase (SYK): structure, mechanisms and drug discovery
    Zhang, Shuangqian
    Wang, Lilin
    Lu, Yingying
    Guo, Chuanxin
    Zhang, Tongtong
    Zhang, Lan
    DRUG DISCOVERY TODAY, 2025, 30 (01)
  • [50] ACTIVITY OF SPLEEN TYROSINE KINASE (SYK) IS REQUIRED FOR DEVELOPMENT OF COLITIS IN MICE
    Raats, D.
    Rijnierse, A.
    Herlaar, E.
    Singh, R.
    Payan, D. G.
    Schmitz, J.
    Bunnett, N.
    Kraneveld, A. D.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2009, 379 (02) : 209 - 210
12345